Metropolis Healthcare Limited (NSE:METROPOLIS) — Market Cap & Net Worth
Market Cap & Net Worth: Metropolis Healthcare Limited (METROPOLIS)
Metropolis Healthcare Limited (NSE:METROPOLIS) has a market capitalization of $299.41 Million (Rs27.69 Billion) as of June 17, 2026. Listed on the NSE stock exchange, this India-based company holds position #14972 globally and #744 in its home market, demonstrating a 0.85% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Metropolis Healthcare Limited's stock price Rs534.15 by its total outstanding shares 51831942 (51.83 Million). Review METROPOLIS current and long-term liabilities to assess the company's total debt and financial obligations.
Metropolis Healthcare Limited Market Cap History: 2019 to 2026
Metropolis Healthcare Limited's market capitalization history from 2019 to 2026. Data shows change from $796.79 Million to $299.41 Million (-7.57% CAGR).
Index Memberships
Metropolis Healthcare Limited is a constituent of 5 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY 500
NIFTY500
|
$3.11 Trillion | 0.01% | #395 of 500 |
|
NIFTY HEALTHCARE
NIFTYHEALTHCARE
|
$110.04 Billion | 0.27% | #13 of 20 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$1.14 Trillion | 0.03% | #318 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.20 Trillion | 0.01% | #532 of 750 |
|
NIFTY SMALLCAP 250
NISM250
|
$385.45 Billion | 0.08% | #207 of 250 |
Weight: Metropolis Healthcare Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Metropolis Healthcare Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Metropolis Healthcare Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.08x
Metropolis Healthcare Limited's market cap is 0.08 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.75x
Metropolis Healthcare Limited's market cap is 0.75 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $796.79 Million | $7.61 Billion | $1.20 Billion | 0.10x | 0.66x |
| 2020 | $1.08 Billion | $8.56 Billion | $1.27 Billion | 0.13x | 0.85x |
| 2021 | $1.90 Billion | $9.98 Billion | $1.83 Billion | 0.19x | 1.04x |
| 2022 | $737.86 Million | $12.28 Billion | $2.14 Billion | 0.06x | 0.34x |
| 2023 | $940.67 Million | $11.48 Billion | $1.43 Billion | 0.08x | 0.66x |
| 2024 | $1.16 Billion | $12.08 Billion | $1.28 Billion | 0.10x | 0.91x |
| 2025 | $1.08 Billion | $13.31 Billion | $1.45 Billion | 0.08x | 0.75x |
Competitor Companies of METROPOLIS by Market Capitalization
Companies near Metropolis Healthcare Limited in the global market cap rankings as of June 17, 2026.
Key companies related to Metropolis Healthcare Limited by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #127 globally with a market cap of $177.57 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #182 globally with a market cap of $128.10 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #626 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #663 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #127 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.57 Billion | $472.63 |
| #182 | Danaher Corporation | NYSE:DHR | $128.10 Billion | $181.35 |
| #626 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $573.00 |
| #663 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Metropolis Healthcare Limited Historical Marketcap From 2019 to 2026
Between 2019 and today, Metropolis Healthcare Limited's market cap moved from $796.79 Million to $ 299.41 Million, with a yearly change of -7.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs299.41 Million | -72.31% |
| 2025 | Rs1.08 Billion | -7.11% |
| 2024 | Rs1.16 Billion | +23.75% |
| 2023 | Rs940.67 Million | +27.49% |
| 2022 | Rs737.86 Million | -61.27% |
| 2021 | Rs1.90 Billion | +76.17% |
| 2020 | Rs1.08 Billion | +35.71% |
| 2019 | Rs796.79 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Metropolis Healthcare Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $299.41 Million USD |
| MoneyControl | $299.41 Million USD |
| MarketWatch | $299.41 Million USD |
| marketcap.company | $299.41 Million USD |
| Reuters | $299.41 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Metropolis Healthcare Limited
Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinic… Read more